Drug details

Gleostine (lomustine capsules)

type of Antineoplastics, Alkylating

Gleostine (lomustine) is a type of anti-cancer drug used to treat brain tumors, both primary and metastatic, in patients who have already received appropriate surgical and/or radiotherapeutic procedures, and to treat Hodgkin's disease, as secondary therapy in combination with other approved drugs in patients who relapse while being treated with primary therapy, or who fail to respond to primary therapy.

This drug may have the following side effects:

• hives,
• difficulty breathing,
• swelling of your face, lips, tongue, or throat,
• fever,
• easy bruising,
• chills,
• tiredness,
• yellowing of the skin or eyes (jaundice),
• trouble swallowing,
• sore throat,
• little or no urination,
• swelling in your feet or ankles,
• chest pain
• unusual bleeding (nose, mouth, vagina, or rectum),
• purple or red pinpoint spots under your skin,
• red or swollen gums,
• new or worsening cough, and
• blisters or ulcers in your mouth,
• shortness of breath (may develop as long as 6 months or later after taking the medication),

The following drugs are related to Gleostine, either as a replacement or used together:

• CeeNU (lomustine capsules)
• Gliadel (polifeprosan 20 with carmustine)
• Temodar (temozolomide)